Results 101 to 110 of about 19,913 (173)

Smoking and <i>Clostridioides difficile</i> Colonization in Adults Aged ≥40 Years: Findings from a Community-Based Gut Microbiota Study. [PDF]

Infect Drug Resist
Chen HM, Yang TW, Ko WC, Hung YP, Tsai CS, Tsai PJ.   +5 more
europepmc   +1 more source

Clinical and Pharmacoeconomic evaluation of Fidaxomicin in patients over 65 years of age and immunocompromised patients with recurrent and refractory Clostridioides difficile infection. [PDF]

BMC Infect Dis
Alram I, Wingen-Heimann SM, Engelhard M, Pfeiffer N, Vehreschild JJ, Vehreschild MJGT, Pütz SM.   +6 more
europepmc   +1 more source

Trends and Impact of <i>Clostridioides difficile</i> Infection on Thirty-Day Readmissions and Outcomes Following Coronary Artery Bypass Grafting: A Seven-Year National Analysis. [PDF]

Gastroenterology Res
Sapkota A, Sherpa N, Grba M, Sigala F, Luna E, Amdetsion GY, Mutneja HR, Kotwal V.   +7 more
europepmc   +1 more source

Evaluation of the microbiological diagnostic algorithm for <i>Clostridioides difficile</i> infection and associated clinical factors in a tertiary care hospital. [PDF]

Rev Esp Quimioter
Muñoz-Dávila MJ, Yague-Guirao G, Hernández A, García-Vázquez E.   +3 more
europepmc   +1 more source

Reducing the incidence of <i>Clostridioides difficile</i> infection through educational and antimicrobial stewardship interventions. [PDF]

J Infect Prev
Nagaoka H, Morita Y, Ohya T, Takahashi K, Sato J, Nishio K, Miyata M, Iwashita S, Arai Y, Kiuchi S, Ozone H, Matsumoto T.   +11 more
europepmc   +1 more source

Toxic Megacolon With a Positive Clostridioides difficile Antigen but Negative Toxin Assay. [PDF]

Cureus
Feyisa MA.
europepmc   +1 more source

Evaluation of the efficacy of inactivated fecal transplants against Clostridioides difficile: an in vitro study. [PDF]

World J Microbiol Biotechnol
Baillieu V, Delannoy J, Kapel N, Barbut F, Mosca A, Joly AC, Waligora-Dupriet AJ, Sintes R.   +7 more
europepmc   +1 more source

Efficacy of UV-C devices in Clostridioides difficile environmental decontamination in a hospital setting: a before-after study. [PDF]

BMC Infect Dis
Fourman N, Houri-Levi E, Meltzer E, Mechnik B, Pinas-Zade N, Maizels L, Eden-Friedman Y, Raibman-Spector S, Regev-Yochay G, Gilboa M.   +9 more
europepmc   +1 more source

Fecal Microbiota Transplantation in 2025: Two Steps Forward, One Step Back. [PDF]

Curr Gastroenterol Rep
Miller CB, Bader GA, Kay CL.
europepmc   +1 more source

Randomized double-blind clinical trial evaluating the effectiveness and safety of secondary prophylaxis with oral vancomycin versus placebo in the prevention of recurrence of <i>clostridioides difficile</i> infection in patients receiving systemic antibiotic therapy (PREVAN trial). [PDF]

JAC Antimicrob Resist
San-Juan R, Origüen J, Fernández-Ruiz M, Campion K, Silva JT, López-Medrano F, Villa J, Díaz-Pollan B, Callejas-Díaz A, Candela G, Boan J, Aparicio-Minguijon E, Asin MAP, Rodriguez-Goncer I, Martín-Arriscado C, Ferrari JM, Aguado JM.   +16 more
europepmc   +1 more source